Global Peptide CDMO Market Research Report 2023(Status and Outlook)

Global Peptide CDMO Market Research Report 2023(Status and Outlook)



Report Overview

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

The Global Peptide CDMO Market Size was estimated at USD 2303.20 million in 2022 and is projected to reach USD 6163.95 million by 2029, exhibiting a CAGR of 15.10% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Peptide CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide CDMO market in any manner.

Global Peptide CDMO Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bachem

PolyPeptide

AmbioPharm

USV Peptides

Thermo Fisher

Bio Basic

JPT

Genscript

Xinbang Pharma

ScinoPharm

SN Biopharm

CBL

Piramal Pharma

CordenPharma

CPC Scientific

Market Segmentation (by Type)

APIs and Intermediates

FDF

Market Segmentation (by Application)

Oil and Gas

Energy Power

Chemical

Water Treatment

Paper Making

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Peptide CDMO Market

Overview of the regional outlook of the Peptide CDMO Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide CDMO
1.2 Key Market Segments
1.2.1 Peptide CDMO Segment by Type
1.2.2 Peptide CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peptide CDMO Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide CDMO Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Peptide CDMO Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peptide CDMO Market Competitive Landscape
3.1 Global Peptide CDMO Sales by Manufacturers (2018-2023)
3.2 Global Peptide CDMO Revenue Market Share by Manufacturers (2018-2023)
3.3 Peptide CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide CDMO Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Peptide CDMO Sales Sites, Area Served, Product Type
3.6 Peptide CDMO Market Competitive Situation and Trends
3.6.1 Peptide CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peptide CDMO Industry Chain Analysis
4.1 Peptide CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peptide CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peptide CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide CDMO Sales Market Share by Type (2018-2023)
6.3 Global Peptide CDMO Market Size Market Share by Type (2018-2023)
6.4 Global Peptide CDMO Price by Type (2018-2023)
7 Peptide CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide CDMO Market Sales by Application (2018-2023)
7.3 Global Peptide CDMO Market Size (M USD) by Application (2018-2023)
7.4 Global Peptide CDMO Sales Growth Rate by Application (2018-2023)
8 Peptide CDMO Market Segmentation by Region
8.1 Global Peptide CDMO Sales by Region
8.1.1 Global Peptide CDMO Sales by Region
8.1.2 Global Peptide CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bachem
9.1.1 Bachem Peptide CDMO Basic Information
9.1.2 Bachem Peptide CDMO Product Overview
9.1.3 Bachem Peptide CDMO Product Market Performance
9.1.4 Bachem Business Overview
9.1.5 Bachem Peptide CDMO SWOT Analysis
9.1.6 Bachem Recent Developments
9.2 PolyPeptide
9.2.1 PolyPeptide Peptide CDMO Basic Information
9.2.2 PolyPeptide Peptide CDMO Product Overview
9.2.3 PolyPeptide Peptide CDMO Product Market Performance
9.2.4 PolyPeptide Business Overview
9.2.5 PolyPeptide Peptide CDMO SWOT Analysis
9.2.6 PolyPeptide Recent Developments
9.3 AmbioPharm
9.3.1 AmbioPharm Peptide CDMO Basic Information
9.3.2 AmbioPharm Peptide CDMO Product Overview
9.3.3 AmbioPharm Peptide CDMO Product Market Performance
9.3.4 AmbioPharm Business Overview
9.3.5 AmbioPharm Peptide CDMO SWOT Analysis
9.3.6 AmbioPharm Recent Developments
9.4 USV Peptides
9.4.1 USV Peptides Peptide CDMO Basic Information
9.4.2 USV Peptides Peptide CDMO Product Overview
9.4.3 USV Peptides Peptide CDMO Product Market Performance
9.4.4 USV Peptides Business Overview
9.4.5 USV Peptides Peptide CDMO SWOT Analysis
9.4.6 USV Peptides Recent Developments
9.5 Thermo Fisher
9.5.1 Thermo Fisher Peptide CDMO Basic Information
9.5.2 Thermo Fisher Peptide CDMO Product Overview
9.5.3 Thermo Fisher Peptide CDMO Product Market Performance
9.5.4 Thermo Fisher Business Overview
9.5.5 Thermo Fisher Peptide CDMO SWOT Analysis
9.5.6 Thermo Fisher Recent Developments
9.6 Bio Basic
9.6.1 Bio Basic Peptide CDMO Basic Information
9.6.2 Bio Basic Peptide CDMO Product Overview
9.6.3 Bio Basic Peptide CDMO Product Market Performance
9.6.4 Bio Basic Business Overview
9.6.5 Bio Basic Recent Developments
9.7 JPT
9.7.1 JPT Peptide CDMO Basic Information
9.7.2 JPT Peptide CDMO Product Overview
9.7.3 JPT Peptide CDMO Product Market Performance
9.7.4 JPT Business Overview
9.7.5 JPT Recent Developments
9.8 Genscript
9.8.1 Genscript Peptide CDMO Basic Information
9.8.2 Genscript Peptide CDMO Product Overview
9.8.3 Genscript Peptide CDMO Product Market Performance
9.8.4 Genscript Business Overview
9.8.5 Genscript Recent Developments
9.9 Xinbang Pharma
9.9.1 Xinbang Pharma Peptide CDMO Basic Information
9.9.2 Xinbang Pharma Peptide CDMO Product Overview
9.9.3 Xinbang Pharma Peptide CDMO Product Market Performance
9.9.4 Xinbang Pharma Business Overview
9.9.5 Xinbang Pharma Recent Developments
9.10 ScinoPharm
9.10.1 ScinoPharm Peptide CDMO Basic Information
9.10.2 ScinoPharm Peptide CDMO Product Overview
9.10.3 ScinoPharm Peptide CDMO Product Market Performance
9.10.4 ScinoPharm Business Overview
9.10.5 ScinoPharm Recent Developments
9.11 SN Biopharm
9.11.1 SN Biopharm Peptide CDMO Basic Information
9.11.2 SN Biopharm Peptide CDMO Product Overview
9.11.3 SN Biopharm Peptide CDMO Product Market Performance
9.11.4 SN Biopharm Business Overview
9.11.5 SN Biopharm Recent Developments
9.12 CBL
9.12.1 CBL Peptide CDMO Basic Information
9.12.2 CBL Peptide CDMO Product Overview
9.12.3 CBL Peptide CDMO Product Market Performance
9.12.4 CBL Business Overview
9.12.5 CBL Recent Developments
9.13 Piramal Pharma
9.13.1 Piramal Pharma Peptide CDMO Basic Information
9.13.2 Piramal Pharma Peptide CDMO Product Overview
9.13.3 Piramal Pharma Peptide CDMO Product Market Performance
9.13.4 Piramal Pharma Business Overview
9.13.5 Piramal Pharma Recent Developments
9.14 CordenPharma
9.14.1 CordenPharma Peptide CDMO Basic Information
9.14.2 CordenPharma Peptide CDMO Product Overview
9.14.3 CordenPharma Peptide CDMO Product Market Performance
9.14.4 CordenPharma Business Overview
9.14.5 CordenPharma Recent Developments
9.15 CPC Scientific
9.15.1 CPC Scientific Peptide CDMO Basic Information
9.15.2 CPC Scientific Peptide CDMO Product Overview
9.15.3 CPC Scientific Peptide CDMO Product Market Performance
9.15.4 CPC Scientific Business Overview
9.15.5 CPC Scientific Recent Developments
10 Peptide CDMO Market Forecast by Region
10.1 Global Peptide CDMO Market Size Forecast
10.2 Global Peptide CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Peptide CDMO Market Size Forecast by Region
10.2.4 South America Peptide CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide CDMO by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Peptide CDMO Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Peptide CDMO by Type (2024-2029)
11.1.2 Global Peptide CDMO Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Peptide CDMO by Type (2024-2029)
11.2 Global Peptide CDMO Market Forecast by Application (2024-2029)
11.2.1 Global Peptide CDMO Sales (K MT) Forecast by Application
11.2.2 Global Peptide CDMO Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings